3 C
London
Saturday, January 28, 2023
HomeOpenness To Medical Cannabis Is Mostly Fairly Low
Array

Openness To Medical Cannabis Is Mostly Fairly Low

Date:

Related stories

Escobar: Can You Smell What The Year Of The Rabbit Is Cooking?

Escobar: Can You Smell What The Year Of The Rabbit Is Cooking? Authored by Pepe Escobar, The New Silk Roads, or BRI, as well as the integration efforts of BRICS+, the SCO and the EAEU will be on the forefront of Chinese policy... Liu H...

Visualizing Remittance Flows & GDP Impact By Country

Visualizing Remittance Flows & GDP Impact By Country The COVID-19 pandemic slowed down the flow of global immigration by 27%. And, as Visual Capitalist's Richie Lionell details below, alongside it, travel restrictions, job losses, and mo...

Canada’s Bill C-26: Yet Another Government Power Grab

Canada's Bill C-26: Yet Another Government Power Grab Authored by Mark Jeftovic via EasyDNS.com, Soviet Era Ethos Stomps Privacy and Due-Process Another doozy from the Canadian government. Following along several other bills winding t...

Thai Rice Prices Jump As Global Food Crisis Reignites

Thai Rice Prices Jump As Global Food Crisis Reignites Soaring rice prices is the latest example of persistent food inflation. The grain is responsible for feeding billions of people, and prices were relatively stable last year while wheat ...

Here’s What Happens To Society When The System Fails

Here's What Happens To Society When The System Fails Authored by Fabiann Ommar via The Organic Prepper blog, When the system begins to fail, society can quickly crumble. Two such events have occurred recently... Let’s reflect on the Br...
Openness To Medical Cannabis Is Mostly Fairly Low

Almost 100,000 new patients were estimated to be able to legally access medical cannabis in the United Kingdom and Europe in 2022, according to a report by industry analysts Prohibition Partners, bringing the region’s total number of medical users to around 342,000. This figure is expected to surpass 500,000 in 2023, as more countries introduce access to legalized medical cannabis and existing markets mature.

According to the researchers' latest report, in 2022, the Spanish government legalized the use of medical cannabis for select conditions through the country’s public health system, while in Ukraine, the Minister of Health said he intends to legalize cannabis for medical purposes as part of the country’s efforts to treat trauma from the war. The trend is also being seen in Latin America, with Costa Rica and Panama having adopted medical cannabis laws for the first time, while in Asia, Malaysia’s Ministry of Health stated its intention to legalize the medical drug.

Medical cannabis is sometimes prescribed to people to ease the symptoms of certain medical conditions. According to the NHS, in the United Kingdom it is currently only prescribed to children and adults with rare, severe forms of epilepsy, to adults with vomiting or nausea caused by chemotherapy, and by people with muscle stiffness and spasms caused by multiple sclerosis (MS). In terms of medical side effects, experts say that abuse of the drug can increase the risk of psychosis and anxiety.

Despite the drug’s ability to relieve pain and improve quality of life, access remains limited for many, as bureaucratic barriers and laws mean it can be difficult to get a hold of.

Stigma remains around the topic in many countries, particularly since the United States’ war on drugs campaign in the 70s, with perceptions slow to change.

But, as Statista's Anna Fleck details below, both cultural and individuals’ views around the use of medical cannabis vary from country to country.

Infographic: Openness To Medical Cannabis Is Mostly Fairly Low | Statista

You will find more infographics at Statista

As Fleck showd in the chart above, pulling from Statista’s Consumer Insight survey, in Spain and France, only 22 and 23 percent of respondents, respectively, said they would be open to trying the medical version of the drug.

This is even lower in South Korea, where only 13 percent would consider using it.

Germany and Poland are among the more receptive of the polled countries, at 39 percent and 46 percent. In Germany, the topic has been in the public eye of late, as the country is currently looking whether to fully legalize cannabis for adults, including recreationally, with plans to have a draft cannabis law drawn up by the end of 2023. Medical marajuana has been legal in the country since 2017 for seriously ill patients.

Susanne Casper, CEO of the pharmaceutical company Linnea SA, tells the writers of the report that as recreational marajuana becomes legalized in more countries, it will be important that it does not wipe out the medical marajuana market, which has high standards for regulations in terms of reliable potency and dosing, and offers the benefit that it can usually be partially covered by health insurance, benefiting patients.

Tyler Durden Wed, 01/25/2023 - 04:15

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

LEAVE A REPLY

Please enter your comment!
Please enter your name here